BRIN: Vaccine development key to Indonesia's health sovereignty
Jakarta (ANTARA) - The National Research and Innovation Agency (BRIN) has stated that vaccine development is one of the keys to Indonesia’s health sovereignty, expressing hope that the collaboration between the University of Indonesia and Tsinghua University on a dengue vaccine will inspire further research and innovation.
BRIN Head Arif Satria said the launch of the vaccine prototype was more than just a celebration; it was tangible proof of international collaboration, scientific excellence, and high dedication that produces real solutions to address problems and pursue the national ambition of health resilience.
“Through this agenda, we want to develop Indonesia’s capacity to develop vaccine technology domestically, accelerate its implementation in applications and practice, and build a resilient national innovation ecosystem,” Arif said.
In line with this goal, his agency is accelerating the development of advanced vaccines to prevent tuberculosis (TB), dengue, and influenza through interdisciplinary collaboration to drive discoveries and innovation in the health sector.
Arif said that through competitive research funding schemes for both preclinical and clinical research, as well as access to various research infrastructures, his agency always invites various parties, including universities, the health industry, and international partners, to collaborate.
His agency also consistently works with the Ministry of Health, the Food and Drug Supervisory Agency (BPOM), the Education Fund Management Institution (LPDP), industry, universities, and global partners to ensure that the vaccines produced are safe, effective, and accessible to the public.
“The true measure of success is our ability to advance this promising prototype through preclinical studies, clinical trials, rigorous industrial-scale production, and ultimately ensure that innovative vaccines are accessible to those who need them most,” Arif said.
He expressed hope that the launch would increase investment in research and development and foster a stronger spirit of collaboration, so that Indonesia’s ambition to become a trusted global vaccine contributor can be achieved.
“Vaccine development is not merely the achievement of one laboratory or institution. It is the culmination of an integrated innovation ecosystem, where basic research, cutting-edge technology, clinical science, production capacity, superior regulation, funding, and international collaboration unite to answer one of society’s most pressing challenges,” Arif said.
Source: jawawa.id (https://jawawa.id/newsitem/brin-vaccine-development-key-to-indonesias-health-sovereignty-1783518839)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5641107/brin-pengembangan-vaksin-salah-satu-kunci-kedaulatan-kesehatan-ri), translated from Indonesian